The European Centre for Disease Prevention and Control (ECDC) has confirmed that the Andes strain of hantavirus shows no signs of genetic mutation capable of driving human-to-human transmission. The assessment follows intensified monitoring of the virus, which is primarily transmitted to humans through contact with the excreta of infected rodents.
Public health officials have been on alert due to the high mortality rate associated with the Andes strain, particularly in South America. While the virus can cause Hantavirus Pulmonary Syndrome (HPS)—a severe respiratory illness—it has historically remained a zoonotic disease. The ECDC’s latest technical report serves to dampen speculation that the virus is evolving to spread easily between people.
“Current data confirms the transmission route remains consistent with historical patterns,” the agency noted in its brief. It emphasized that sporadic cases reported in endemic regions do not indicate a shift in the pathogen’s biological behavior or environmental stability.
The Andes virus remains a localized threat, largely contained within specific rodent populations in Argentina and Chile. Unlike other viruses that trigger global concern through rapid adaptation, this strain depends entirely on direct contact with contaminated environments.
Public health experts maintain that the primary defense remains ecological management. Preventing contact with rodent nests and maintaining hygiene in rural areas are the only proven methods to curb infection.
Despite the ECDC’s findings, medical teams in the affected regions continue to monitor patients closely. The focus remains on early clinical intervention, as the window for effective treatment for HPS is narrow. For now, the threat remains contained to its traditional biological boundaries, with no evidence of the viral evolution that would spark a wider public health crisis.
